Daiichi Sankyo Articles
Japan stock market week to Feb 12, 2007
19 February 2007
Japan stock market week to Feb 5, 2007
12 February 2007
Japan stock market week to June 25, 2007
7 February 2007
Japan stock market week to Jan 22, 2007
29 January 2007
Ph III prasugrel trial completes enrollment
29 January 2007
Japan stock market week to Jan 15, 2007
22 January 2007
Daiichi Sankyo submits sNDA for WelChol
15 January 2007
Patent expiry will "constrain" antibacterial market
15 January 2007
Japan stock market week to Jan 8, 2007
15 January 2007
Japan stock market week to Dec 11, 2006
18 December 2006
Japan stock market week to Dec 4, 2006
11 December 2006
Daiichi Sankyo files NDA for combo CV drug
4 December 2006
Daiichi Sankyo discusses R&D pipeline
27 November 2006
Japan stock market week to Nov 13, 2006
20 November 2006
Daiichi Sankyo's first-half profit jumps 35.3%
13 November 2006
Japan stock market week to Oct 30, 2006
6 November 2006
Japan stock market week to October 9, 2006
16 October 2006
Stock Commentary - Tokyo week to Oct 2, 2006
9 October 2006
Stock Commentary - Tokyo - week to Sept 25, 2006
2 October 2006
Japan stock market week to Sept 18, 2006
25 September 2006
Japan stock market week to Sept 11, 2006
18 September 2006
Japan stock market week to Sept 4, 2006
11 September 2006
Japan stock market week to Aug 7, 2006
14 August 2006
YM Bio licenses cancer drug to Daiichi Sankyo
7 August 2006
Industry bodies oppose annual revision of Japan
7 August 2006
Japan stock market week to July 24, 2006
26 July 2006
Japan stock market week to July 17, 2006
24 July 2006
Japan stock market week to June 26, 2006
3 July 2006
Japan stock market week to June 12, 2006
19 June 2006
Japan stock market week to May 29, 2006
5 June 2006
MorphoSys sees 100% 1st-qtr income rise
22 May 2006
Japan stock market week to May 15, 2006
22 May 2006
Daichii Sankyo's 2005/6 net income up 9.7%
22 May 2006
Japan stock market week to May 8, 2006
15 May 2006
Daiichi Sankyo to buy Zepharma for $200M
10 April 2006
MorphoSys and Sankyo enter R&D accord
27 March 2006
MorphoSys and Sankyo enter R&D accord
20 March 2006
Japan's pharma licks its wounds after NHI cuts
13 March 2006
Japan stock market week to Feb 20, 2006
27 February 2006
Daiichi Sankyo sees increase in 2005 income
20 February 2006
Sankyo licenses KAI's PKC inhibitor CV drug
30 January 2006
KAI Pharma enters CV accord with Daiichi Sankyo
16 January 2006
Daiichi Sankyo: 8% half-year income rise
12 December 2005
Japan stock market week to Nov 28
5 December 2005
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
